New patent for On Target drug CYTALUX

Annual Drug Patent Expirations for CYTALUX Cytalux is a drug marketed by On Target Labs and is included in one NDA. The generic ingredient in CYTALUX is pafolacianine sodium. Additional…
The post New patent for On Target drug CYTALUX appeared first on …


Drug Patent Expirations for the Week of January 23, 2022

ABILIFY MAINTENA KIT (aripiprazole) Otsuka pharm co ltd Patent: 9,089,567 Expiration: Jan 28, 2022 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence…
The post Drug Patent Expirations for the …


Get email updates

Get new actionable insights and updates from BiotechBlog

Biotechblog